Has Pegge Halandras, MD received payments from drug or device companies?

Yes. Drug and device makers reported $33,254 in general payments to Pegge Halandras, MD across 107 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Pegge Halandras, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Pegge Halandras, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Pegge Halandras, MD

Vascular Surgery · Maywood, ILNPI 1649458753

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $23,700 of the $33,254 with a category attached, or 71.3%. Medtronic accounts for 79.2% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $23,249 and has fallen 99.1% since, to $217 in 2025.

$33,254in general payments, 2019–2025

Across 107 payments — averaging $310.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$26K
Bolton Medical Inc$5K
Terumo Medical Corporation$531
W. L. Gore & Associates, Inc.$290
Penumbra, Inc.$281
Shockwave Medical, Inc$269
plus $645 from 12 others

$15,400in research payments, 2019–2025

Across 11 payments — averaging $1400.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

W. L. Gore & Associates, Inc.$15K

What the payments were for

Speaking & faculty fees$23,70071%
Travel & lodging$4,59414%
Food & beverage$4,96115%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	67	$26,336
Bolton Medical Inc	6	$4,901
Terumo Medical Corporation	9	$531
W. L. Gore & Associates, Inc.	2	$290
Penumbra, Inc.	2	$281
Shockwave Medical, Inc	2	$269
Inari Medical, Inc.	2	$174
Bard Peripheral Vascular, Inc.	3	$140
Endologix LLC	2	$72
Convatec Inc.	1	$61
Cook Medical LLC	3	$59
Silk Road Medical, Inc.	1	$36
Argon Medical Devices, Inc.	2	$28
Tactile Systems Technology Inc	1	$22
Johnson & Johnson	1	$18
Amgen	1	$13
Surmodics, Inc.	1	$12
Elutia, Inc.	1	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ENDURANT IIS$23,438
Relay Grafts$3,000
Endurant$848
RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$750
Grafts$401
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$172
FLOWTRIEVER CATHETER, S$154
CT THROMBECTOMY SYSTEM KIT$154
Vascular Lithotripsy$148
Smart Coil$143
Indigo$138
Penumbra Ruby Coil$138
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$121
VIABAHN VBX Balloon Expandable Endoprosthesis$118
GLIDESHEATH SLENDER$117

How this compares

$33,254 in reported general payments places this provider in the 85th percentile of 170 vascular surgery providers in Illinois.

See all vascular surgery providers in Illinois →

Medicare billing

Part B allowed, 2024

$94,533

Medicare patients

542

Services billed

1,085

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	13	$6,715
ClopidogrelClopidogrel Bisulfate	39	$552
Gabapentin	12	$90

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Maywood

Carlos BecharaMaywood$199K
Michael SoultMaywood$104K
Paul CrisostomoMaywood$95K
Ruojia LiMaywood$12K
Ross MilnerChicago$1.3M
Sapan DesaiArlington Heights$1.2M
Nabeel RanaPeoria$934K
Atif BaqaiPark Ridge$567K
Trissa BabrowskiChicago$292K
Tejas ShahDowners Grove$213K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →